China Kangtai Cactus Biotech Retains Hawk Associates for Investor Relations Services
Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower,
developer, manufacturer and marketer of cactus-based consumer products in
for strategic investor relations. Information about China Kangtai will be
available through the Hawk Associates website at:
http://www.hawkassociates.com , featuring company updates, investor
information and live financial feeds.
China Kangtai CEO
Hawk Associate, which has been providing comprehensive strategic IR services
for 14 years in their roles as trusted advisors. We believe Hawk Associates is
one of the premier investor relations firms that effectively helps companies
successfully communicate their stories to the investment community. The
branding and investor relations expertise that Hawk provides will be essential
in assisting management in showcasing the true value of our company.”
Hawk Associates CEO
market share of
beneficiary of growing Chinese demand for health and wellness products. In
such as diabetes, adiposity, constipation, cholesterol, high blood pressure,
low immunity and skin disorders. This is a unique company in an unsaturated
industry. With the company’s recent acquisition in March, Kangtai is seeking
to increase its production capabilities in an effort to enhance its overall
growth. We are thrilled to be able to help Kangtai tell its story to the
investment community to strengthen its long-term valuation.”
About China Kangtai Cactus Biotech, Inc.
China Kangtai Cactus Biotech Inc. is a leading grower, developer, producer
and marketer of cactus-derived products, including nutraceuticals, nutritional
food and drinks, and animal feed. China Kangtai controls over 387 acres of
plants and maintains an active R&D group that holds 18 product patents and is
seeking another 12 in a variety of product categories. China Kangtai’s
high-quality “green” products are sold throughout
stores, hotels and restaurants through a growing distribution network that has
currently covered 12 provinces and 2 municipalities. For more information,
please contact:
Inc. Email: chinakangtai@gmail.com
For more investor-related questions, contact
at 305-451-1888. To subscribe to future releases via e-mail alert, visit
http://www.hawkassociates.com/about/alert/ .
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future
events or performance, and underlying assumptions and other statements that
are other than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks contained
in reports filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements. In addition, the company disclaims any obligation
to update any forward-looking statements to reflect events or circumstances
after the date hereof.
SOURCE China Kangtai Cactus Biotech, Inc.
